Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Formation of wave packets in the Ostrovsky equation for both normal and anomalous dispersion.

Grimshaw R, Stepanyants Y, Alias A.

Proc Math Phys Eng Sci. 2016 Jan;472(2185):20150416.

2.

Death of the anaesthetic room III.

Grimshaw R.

Anaesthesia. 2015 Jul;70(7):886. doi: 10.1111/anae.13130. No abstract available.

3.

A coupled "AB" system: Rogue waves and modulation instabilities.

Wu CF, Grimshaw RH, Chow KW, Chan HN.

Chaos. 2015 Oct;25(10):103113. doi: 10.1063/1.4931708.

PMID:
26520079
4.

Rogue wave modes for a derivative nonlinear Schrödinger model.

Chan HN, Chow KW, Kedziora DJ, Grimshaw RH, Ding E.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Mar;89(3):032914. Epub 2014 Mar 17.

PMID:
24730920
5.

Modified reduced Ostrovsky equation: integrability and breaking.

Johnson ER, Grimshaw RH.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Aug;88(2):021201. Epub 2013 Aug 27.

PMID:
24032767
6.

On strongly interacting internal waves in a rotating ocean and coupled Ostrovsky equations.

Alias A, Grimshaw RH, Khusnutdinova KR.

Chaos. 2013 Jun;23(2):023121. doi: 10.1063/1.4808249.

PMID:
23822486
7.

Nonlinear wave evolution equation for critical layers.

Caillol P, Grimshaw R.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Oct;86(4 Pt 2):046311. Epub 2012 Oct 12.

PMID:
23214681
8.

Undular bore theory for the Gardner equation.

Kamchatnov AM, Kuo YH, Lin TC, Horng TL, Gou SC, Clift R, El GA, Grimshaw RH.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Sep;86(3 Pt 2):036605. Epub 2012 Sep 18.

PMID:
23031043
9.

Management of mixed urinary incontinence.

Grimshaw R, Jain P, Latthe P.

Womens Health (Lond). 2012 Sep;8(5):567-77. doi: 10.2217/whe.12.38.

PMID:
22934730
10.

Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.

Hoskins P, Vergote I, Cervantes A, Tu D, Stuart G, Zola P, Poveda A, Provencher D, Katsaros D, Ojeda B, Ghatage P, Grimshaw R, Casado A, Elit L, Mendiola C, Sugimoto A, D'Hondt V, Oza A, Germa JR, Roy M, Brotto L, Chen D, Eisenhauer EA.

J Natl Cancer Inst. 2010 Oct 20;102(20):1547-56. doi: 10.1093/jnci/djq362. Epub 2010 Oct 11.

11.

A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study.

Biagi JJ, Oza AM, Chalchal HI, Grimshaw R, Ellard SL, Lee U, Hirte H, Sederias J, Ivy SP, Eisenhauer EA.

Ann Oncol. 2011 Feb;22(2):335-40. doi: 10.1093/annonc/mdq357. Epub 2010 Aug 12.

PMID:
20705911
12.

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).

Hirte H, Oza A, Swenerton K, Ellard SL, Grimshaw R, Fisher B, Tsao M, Seymour L.

Gynecol Oncol. 2010 Sep;118(3):308-12. doi: 10.1016/j.ygyno.2010.05.005. Epub 2010 Jun 19.

PMID:
20646751
13.

Generation of solitons and breathers in the extended Korteweg-de Vries equation with positive cubic nonlinearity.

Grimshaw R, Slunyaev A, Pelinovsky E.

Chaos. 2010 Mar;20(1):013102. doi: 10.1063/1.3279480.

PMID:
20370257
14.

Value of targeting at-risk populations at outreach venues: findings from a local sauna.

Arumainayagam J, Grimshaw R, Acharya S, Chandramani S, Morrall IA, Pugh RN.

Int J STD AIDS. 2009 Sep;20(9):642-3. doi: 10.1258/ijsa.2008.008424.

PMID:
19710339
15.

Risk of malignancy index in the evaluation of patients with adnexal masses.

Clarke SE, Grimshaw R, Rittenberg P, Kieser K, Bentley J.

J Obstet Gynaecol Can. 2009 May;31(5):440-5.

PMID:
19604425
16.
17.

Analytic model for a weakly dissipative shallow-water undular bore.

El GA, Grimshaw RH, Kamchatnov AM.

Chaos. 2005 Sep;15(3):37102.

PMID:
16252997
18.

Solitons in nonintegrable systems.

Grimshaw RH, Ostrovsky LA, Pelinovsky DE.

Chaos. 2005 Sep;15(3):37101.

PMID:
16252996
19.

Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models.

Banerji U, Walton M, Raynaud F, Grimshaw R, Kelland L, Valenti M, Judson I, Workman P.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7023-32.

20.

Complementary and alternative medicine in gynaecologic oncology.

McKay DJ, Bentley JR, Grimshaw RN.

J Obstet Gynaecol Can. 2005 Jun;27(6):562-8.

PMID:
16100633
21.

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Dark GG, Calvert AH, Grimshaw R, Poole C, Swenerton K, Kaye S, Coleman R, Jayson G, Le T, Ellard S, Trudeau M, Vasey P, Hamilton M, Cameron T, Barrett E, Walsh W, McIntosh L, Eisenhauer EA.

J Clin Oncol. 2005 Mar 20;23(9):1859-66. Epub 2005 Feb 7.

PMID:
15699482
22.

A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen.

Johnston SR, Gumbrell LA, Evans TR, Coleman RE, Smith IE, Twelves CJ, Soukop M, Rea DW, Earl HM, Howell A, Jones A, Canney P, Powles TJ, Haynes BP, Nutley B, Grimshaw R, Jarman M, Halbert GW, Brampton M, Haviland J, Dowsett M, Coombes RC; Cancer Research UK Phase I/II Committee.

Cancer Chemother Pharmacol. 2004 Apr;53(4):341-8. Epub 2004 Jan 13.

PMID:
14722733
23.

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer.

Piccart MJ, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy JA, Lhoas F, Lidvall B, Bacon M, Birt A, Andersen J, Zee B, Paul J, Pecorelli S, Baron B, McGuire W.

Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:144-8.

PMID:
14656271
24.

A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy.

Seddon BM, Payne GS, Simmons L, Ruddle R, Grimshaw R, Tan S, Turner A, Raynaud F, Halbert G, Leach MO, Judson I, Workman P.

Clin Cancer Res. 2003 Nov 1;9(14):5101-12. Review.

25.

Effectiveness of letters to Cape Breton women who have not had a recent Pap smear.

Johnston GM, Boyd CJ, MacIsaac MA, Rhodes JW, Grimshaw RN.

Chronic Dis Can. 2003 Spring-Summer;24(2-3):49-56.

PMID:
12959674
26.

Generation of large-amplitude solitons in the extended Korteweg-de Vries equation.

Grimshaw R, Pelinovsky D, Pelinovsky E, Slunyaev A.

Chaos. 2002 Dec;12(4):1070-1076.

PMID:
12779630
27.

Generation of undular bores in the shelves of slowly-varying solitary waves.

El GA, Grimshaw RH.

Chaos. 2002 Dec;12(4):1015-1026.

PMID:
12779625
28.

Dispersion management for solitons in a Korteweg-de Vries system.

Clarke S, Malomed BA, Grimshaw R.

Chaos. 2002 Mar;12(1):8-15.

PMID:
12779527
29.

On the generation of solitons and breathers in the modified Korteweg-de Vries equation.

Clarke S, Grimshaw R, Miller P, Pelinovsky E, Talipova T.

Chaos. 2000 Jun;10(2):383-392.

PMID:
12779394
30.

Singular and regular gap solitons between three dispersion curves.

Grimshaw R, Malomed BA, Gottwald GA.

Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Jun;65(6 Pt 2):066606. Epub 2002 Jun 14.

PMID:
12188850
31.

Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy.

Seddon BM, Maxwell RJ, Honess DJ, Grimshaw R, Raynaud F, Tozer GM, Workman P.

Clin Cancer Res. 2002 Jul;8(7):2323-35.

32.

Hamiltonian-versus-energy diagrams in soliton theory.

Akhmediev N, Ankiewicz A, Grimshaw R.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1999 May;59(5 Pt B):6088-96.

PMID:
11969594
33.

Epoetin alfa in cancer patients: evidence-based guidelines.

Turner R, Anglin P, Burkes R, Couture F, Evans W, Goss G, Grimshaw R, Melosky B, Paterson A, Quirt I; Canadian Cancer and Anemia Guidelines Development Group.

J Pain Symptom Manage. 2001 Nov;22(5):954-65. Review.

PMID:
11728799
34.

Tailoring new physicians to fit your practice.

Grimshaw R.

Fam Pract Manag. 2001 Apr;8(4):39-43. No abstract available.

35.

Phase II feasibility study of sequential couplets of Cisplatin/Topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

Hoskins P, Eisenhauer E, Vergote I, Dubuc-Lissoir J, Fisher B, Grimshaw R, Oza A, Plante M, Stuart G, Vermorken J.

J Clin Oncol. 2000 Dec 15;18(24):4038-44.

PMID:
11118464
36.

Soliton formation from a pulse passing the zero-dispersion point in a nonlinear Schrodinger equation

Clarke SR, Grimshaw RH, Malomed BA.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000 May;61(5B):5794-801.

PMID:
11031639
37.

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

Piccart MJ, Bertelsen K, James K, Cassidy J, Mangioni C, Simonsen E, Stuart G, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson RJ, Swenerton KD, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy JA, Lhoas F, Lindvall B, Bacon M, Birt A, Andersen JE, Zee B, Paul J, Baron B, Pecorelli S.

J Natl Cancer Inst. 2000 May 3;92(9):699-708.

PMID:
10793106
38.

A gender for change.

Grimshaw R.

Nurs Times. 1999 Aug 25-31;95(34):38-9. No abstract available.

PMID:
10647419
39.

Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.

Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M.

Cancer Res. 1999 Aug 1;59(15):3646-51.

40.

Inhibition of protein prenylation by metabolites of limonene.

Hardcastle IR, Rowlands MG, Barber AM, Grimshaw RM, Mohan MK, Nutley BP, Jarman M.

Biochem Pharmacol. 1999 Apr 1;57(7):801-9.

PMID:
10075086
41.

Caloric restriction leads to regional specialisation of adipocyte function in the rat.

Sugden MC, Grimshaw RM, Holness MJ.

Biochim Biophys Acta. 1999 Feb 25;1437(2):202-13.

PMID:
10064903
42.

When two souls meet.

Grimshaw R.

Nurs Stand. 1998 May 27-Jun 2;12(36):26-7.

PMID:
9732610
43.

Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Hoskins P, Eisenhauer E, Beare S, Roy M, Drouin P, Stuart G, Bryson P, Grimshaw R, Capstick V, Zee B.

J Clin Oncol. 1998 Jun;16(6):2233-7.

PMID:
9626225
44.

Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.

Rowlands MG, Grimshaw R, Jarman M, Bouhoute A, Leclercq G.

Biochem Pharmacol. 1997 Jan 24;53(2):241-4.

PMID:
9037257
45.

Oestrogen formation in breast: clinical and biological importance.

Dowsett M, Detre S, Rowlands M, Grimshaw R.

J Endocrinol. 1996 Sep;150 Suppl:S59-63.

PMID:
8943788
46.

Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.

Hardcastle IR, Rowlands MG, Grimshaw RM, Houghton J, Jarman M.

J Med Chem. 1996 Feb 16;39(4):999-1004.

PMID:
8632423
47.

The control and biological importance of intratumoural aromatase in breast cancer.

Dowsett M, Lee K, Macaulay VM, Detre S, Rowlands M, Grimshaw R.

J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):145-50. Review.

PMID:
8603035
48.

The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.

Jarman M, Poon GK, Rowlands MG, Grimshaw RM, Horton MN, Potter GA, McCague R.

Carcinogenesis. 1995 Apr;16(4):683-8.

PMID:
7728943
49.

Regional variations in metabolic responses of white adipose tissue to food restriction.

Sugden MC, Grimshaw RM, Lall H, Holness MJ.

Am J Physiol. 1994 Dec;267(6 Pt 1):E892-9.

PMID:
7810631
50.

Supplemental Content

Loading ...
Support Center